Form D/A — BioIntelliSense, Inc.
0001824134-26-000001 · filed Jun 4, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Other filings
Offering
- Industry
- Other
- Exemptions
- 06b
- Reported offering amount
- $58,350,027
- Reported amount sold
- $58,349,365
- Minimum investment
- $0
- Investors
- 14
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- BioIntelliSense, Inc.
- CIK
- 1824134
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 17301 W. COLFAX AVENUE
GOLDEN, CO 80401 - Phone
- 720-689-9008
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
David Wang · Executive OfficerGolden, CO Find on LinkedIn ↗
-
James Mault · Executive OfficerGolden, CO Find on LinkedIn ↗
-
Conlan Ma · DirectorGolden, CO Find on LinkedIn ↗
-
Xinyaun Yu · DirectorGolden, CO Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗